Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

Clinical Trials: Overview01:11

Clinical Trials: Overview

4.5K
Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
4.5K
Clinical Trials01:16

Clinical Trials

10.1K
Clinical trials are prospective experimental studies conducted on humans to determine the safety and efficacy of treatments, drugs, diet methods, and medical devices. Using statistics in clinical trials enables researchers to derive reasonable and accurate conclusions from the collected data, allowing them to make wise decisions in uncertain situations. In medical research, statistical methods are crucial for preventing errors and bias.
There are four phases in a clinical trial. A phase one...
10.1K
Parkinson's Disease: Overview01:15

Parkinson's Disease: Overview

1.7K
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
1.7K
Myasthenia Gravis: Diagnostic Tests01:15

Myasthenia Gravis: Diagnostic Tests

1.9K
Myasthenia gravis is an autoimmune condition affecting neuromuscular transmission, causing generalized weakness in skeletal muscles. Initial diagnoses rely on patients' signs, symptoms, and medical history. The challenge lies in distinguishing myasthenia from other muscular dystrophies. An important diagnostic feature is the significant improvement of symptoms after administering anticholinesterase inhibitors.
The edrophonium test is a diagnostic tool for myasthenia gravis. It involves...
1.9K
Parkinson's Disease: Treatment01:24

Parkinson's Disease: Treatment

963
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
963

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

The relationship between cerebellar functional connectivity alterations and hand dexterity impairment in multiple sclerosis.

Journal of neurology·2026
Same author

Anti-CD20 Therapies in Pediatric Acquired Demyelinating Syndromes: Evidence Across MS, AQP4-IgG-Positive NMOSD and MOGAD.

CNS drugs·2026
Same author

T1W/T2W Ratio to Assess Brain Microstructural Damage in Multiple Sclerosis: A Multicenter Study.

AJNR. American journal of neuroradiology·2026
Same author

An automated quantitative report for multiple sclerosis using only 3D T2-fluid-attenuated inversion recovery MRI.

Neuroradiology·2026
Same author

Structural MRI signature of late- versus adult-onset multiple sclerosis: a multiparametric study.

Journal of neurology·2026
Same author

Lifespan Modeling of Choroid Plexus Volume in Multiple Sclerosis and Its Dynamic Associations With Clinical, MRI, and HLA Susceptibility.

Neurology(R) neuroimmunology & neuroinflammation·2026

相关实验视频

Updated: Jan 13, 2026

Measuring Progressive Neurological Disability in a Mouse Model of Multiple Sclerosis
08:11

Measuring Progressive Neurological Disability in a Mouse Model of Multiple Sclerosis

Published on: November 14, 2016

11.5K

渐进性多发性硬化症:需要关注的六项试验

Maria A Rocca1, Paolo Preziosa1, Massimo Filippi2

  • 1Neuroimaging Research Unit, Division of Neuroscience, IRCCS San Raffaele Scientific Institute, Milan, Italy; Neurology Unit, IRCCS San Raffaele Scientific Institute, Milan, Italy; Vita-Salute San Raffaele University, Milan, Italy.

Med (New York, N.Y.)
|January 10, 2026
PubMed
概括
此摘要是机器生成的。

进展性多发性硬化症 (PMS) 的新疗法向中枢神经系统炎症. 六项试验调查了布鲁顿的氨酸激酶抑制剂,CD40-CD40L阻断和CAR-T细胞,以治疗微质细胞和B细胞病理.

更多相关视频

The Multiple Sclerosis Performance Test MSPT: An iPad-Based Disability Assessment Tool
11:35

The Multiple Sclerosis Performance Test MSPT: An iPad-Based Disability Assessment Tool

Published on: June 30, 2014

58.6K
Magnetic Resonance Imaging of Multiple Sclerosis at 7.0 Tesla
08:51

Magnetic Resonance Imaging of Multiple Sclerosis at 7.0 Tesla

Published on: February 19, 2021

9.7K

相关实验视频

Last Updated: Jan 13, 2026

Measuring Progressive Neurological Disability in a Mouse Model of Multiple Sclerosis
08:11

Measuring Progressive Neurological Disability in a Mouse Model of Multiple Sclerosis

Published on: November 14, 2016

11.5K
The Multiple Sclerosis Performance Test MSPT: An iPad-Based Disability Assessment Tool
11:35

The Multiple Sclerosis Performance Test MSPT: An iPad-Based Disability Assessment Tool

Published on: June 30, 2014

58.6K
Magnetic Resonance Imaging of Multiple Sclerosis at 7.0 Tesla
08:51

Magnetic Resonance Imaging of Multiple Sclerosis at 7.0 Tesla

Published on: February 19, 2021

9.7K

科学领域:

  • 神经免疫学 神经免疫学
  • 临床治疗学 临床治疗学
  • 翻译医学是一种翻译医学.

背景情况:

  • 渐进性多发性硬化症 (PMS) 的特征是中枢神经系统炎症,驱动疾病的进展独立于复发活动.
  • 目前对PMS的治疗模式有限,这代表了大量未满足的临床需求.
  • 新兴的治疗策略旨在解决PMS的潜在免疫病理.

研究的目的:

  • 审查针对中枢神经系统分隔炎症的新兴疗法,以治疗渐进性多发性硬化症 (PMS).
  • 要突出关键的临床试验评估新型免疫调节剂的PMS.
  • 讨论这些疗法的潜力,通过向关键细胞通路来重新定义PMS治疗.

主要方法:

  • 对进展性多发性硬化症 (PMS) 的六项关键临床试验的审查.
  • 专注于包括布鲁顿氨酸激酶 (BTK) 抑制剂,CD40-CD40L阻断和CD19导向的化学抗原受体 (CAR) -T细胞在内的疗法.
  • 针对微质细胞和B细胞病理学的作用机制的分析.

主要成果:

  • 一些新的治疗类正在为PMS进行研究.
  • 这些药物向与神经炎症和神经退行相关的不同的免疫路径.
  • 早期的数据表明,在MS的渐进形式中,可能存在疾病修饰的可能性.

结论:

  • 针对中枢神经系统炎症的新兴疗法在治疗渐进性多发性硬化症 (PMS) 方面表现有前途.
  • 调节微质细胞和B细胞活动是未来PMS治疗的关键策略.
  • 这些进展可能会显著改善PMS未满足的临床需求的患者的结果.